Impact of Graduation on Child Development in Uganda - Wave 2 (Ancillary/Extension)
NCT ID: NCT07212374
Last Updated: 2025-10-08
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
ACTIVE_NOT_RECRUITING
NA
2100 participants
INTERVENTIONAL
2025-08-20
2025-11-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Wave 2 expands the eligible child age range (0-9 years) and includes age-appropriate outcomes (e.g., IDELA for school readiness; Raven's Progressive Matrices and executive function tasks for older children). We will compare children in households assigned to receive the Graduation program in the parent RCT (T1) to children in pure ("spillover") control households (C2) in host communities. Primary completion is anticipated in October 2025. Pre-analysis plans for Wave 1 and Wave 2 are posted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Efficacy Testing of a Multi-Level Family Planning Intervention
NCT06923189
A Livelihood Intervention for Impoverished Women and Children in Rural Uganda
NCT02619279
Peer Groups to Improve Infant Feeding Practices and Child Growth in Post-emergency Settlements in Uganda
NCT05584969
Testing the Impact of Family-Based Intervention to Improve Developmental and Health Outcomes for Female Adolescents
NCT07278934
Intervention to Improve Developmental and Health Outcomes for Female Adolescents
NCT04231669
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
T1 (Graduation): households in host communities assigned to receive the Graduation program in the parent trial;
C2 (pure "spillover" control): households in host control communities.
Wave 2 purpose: To measure child development and school readiness outcomes in an expanded age range (0-9 years) using validated, age-appropriate instruments.
Design note: Wave 2 is observational with exposure defined by prior random assignment in the parent RCT; there is no new assignment of interventions in Wave 2.
Documents: The Pre-Analysis Plan (PAP) for this Wave 2 is available under Study Documents and cross-references the PAP from Wave 1 (NCT05531812).
Linkage to parent study: This record is explicitly linked to NCT05531812 and AEARCTR-0004080 \[AEA RCT Registry\].
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
OTHER
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Pure ("Spillover") Control (C2)
Children aged 0-9 years living in host-community households in pure control communities (no Graduation program) from the parent RCT
No interventions assigned to this group
Graduation (T1)
Children aged 0-9 years living in host-community households assigned to receive the Graduation program in the parent RCT (no new assignment in Wave 2).
Graduation
"Graduation" is a multifaceted approach that aims to support ultra-poor households in permanently escaping poverty traps. The standard version of Graduation tested in this study includes: a one-time asset transfer; monthly cash transfers; life skills coaching on topics like health and nutrition; technical skills training on topics like financial literacy; and access to savings services.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Graduation
"Graduation" is a multifaceted approach that aims to support ultra-poor households in permanently escaping poverty traps. The standard version of Graduation tested in this study includes: a one-time asset transfer; monthly cash transfers; life skills coaching on topics like health and nutrition; technical skills training on topics like financial literacy; and access to savings services.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Resides in a host-community household within the G2R trial sample
* Caregiver provides informed consent; child provides assent where applicable.
Exclusion Criteria
* Not resident in the study communities at time of assessment.
6 Months
119 Months
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Innovations for Poverty Action
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Lasse Brune, PhD
Role: PRINCIPAL_INVESTIGATOR
Northwestern University
Nathanael Goldberg, MPA
Role: PRINCIPAL_INVESTIGATOR
Innovations for Poverty Action
Dean Karlan, PhD
Role: PRINCIPAL_INVESTIGATOR
Northwestern University
Christopher Udry, PhD
Role: PRINCIPAL_INVESTIGATOR
Northwestern University
Peter Rockers, ScD
Role: PRINCIPAL_INVESTIGATOR
Boston University
Doug Parkerson, MA
Role: PRINCIPAL_INVESTIGATOR
Innovations for Poverty Action
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Innovations for Poverty Action Uganda
Kampala, , Uganda
Countries
Review the countries where the study has at least one active or historical site.
Provided Documents
Download supplemental materials such as informed consent forms, study protocols, or participant manuals.
Document Type: Statistical Analysis Plan
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
NCT05531812 (IPA-2022-UG)
Identifier Type: REGISTRY
Identifier Source: secondary_id
AEARCTR-0004080
Identifier Type: REGISTRY
Identifier Source: secondary_id
IPA-2025-UG-Wave2
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.